Better Therapeutics (BTTX) Gains 20%+ Following New Buy Rating

November 24, 2021 9:44 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Better Therapeutics (NASDAQ: BTTX) gains 23% off the open following this morning's bullish new rating and $17 price target at Chardan.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Related Entities

Chardan Capital Markets